Japan’s Dentsu Invests in Device Company Cue
Dentsu Venture Global Fund I has invested an undisclosed sum in Cue, a medical device company.
Headquartered in San Diego, Calif., Cue manufactures an at-home device for tracking health information at the molecular level.
The cube-shaped device is designed to have diagnostic cartridges inserted for analysis of healthcare data. Through a sample of blood, saliva or mucus, the device can track health indicators such as vitamin D, testosterone, inflammation, influenza and fertility.
Cue is aiming to launch the product in the EU and Hong Kong in the second quarter of 2016 after it receives approval from regulatory authorities. U.S. and Japan launches are planned for 2016 and 2017, respectively. — Michael Cipriano